An Open Ended equity
scheme investing in Pharma and Healthcare Services Sector
Key Highlights
· NFO
opens on June 20, 2019 and closes on July 4, 2019
· Fund
will invest in companies belonging to Indian Pharma, Hospitals, Diagnostics,
Wellness & Speciality Chemicals, Contract Research and Manufacturing
Services
· Minimum
application amount is Rs. 1,000 for the scheme
Aditya Birla Sun Life
Mutual Fund, the mutual fund arm of Aditya Birla Capital Limited, has launched
the Aditya Birla Sun Life Pharma & Healthcare Fund, an open ended
equity scheme investing in Pharma and Healthcare Services Sector.
The fund opens on June 20, 2019.
The
Indian Pharma Industry is projected to become US$100bn industry by 2030, with
domestic pharma expected to grow at 10-12% per annum. Indian Pharma companies
are global leaders in generic drug manufacturing, in fact 1 in every 3
medications sold in the US is supplied by an Indian Pharma Company. The gradual
global shift from branded to generic drugs will act as a tailwind and further
fuel the exports market for Indian Pharma. Increased Government spending on
public healthcare through schemes like ‘Ayushman Bharat’, growing penetration
of health insurance, higher life expectancy and increasing spends towards
healthcare and wellness will act as a stimulus for growth.
Commenting
on the launch, A. Balasubramanian, CEO, Aditya Birla Sun Life AMC Ltd,
said “The sector has been a long term outperformer over a 10 year period,
except in the past 2-3 year. Poised for a strong rebound, there is opportunity
in the coming market cycle to invest, given the attractive valuations and the
potential growth in the sector”.
 |
| Mr. A. Balasubramanian, CEO, Aditya Birla Sun Life AMC Ltd |
With
a new business cycle coming into play and new businesses with high growth
potential and sticky profit like Diagnostics, Wellness & Specialty
Chemicals also available to invest in, this sector is more vibrant than ever
before. “To add to novelty, we also have ability to invest in innovators,
patent holders & specialty instrument makers in global markets”, added A
Balasubramanian.
The fund will be
managed by Mr. Dhaval Shah. The benchmark index for the fund is S&P BSE
Healthcare TRI (Total Return Index).
Data Source: IBEF,
Internal Estimate, Evaluate Pharma, pmjay.gov.in, UN World Population
Prospects, Mckinsey Global Institute report, National Health Profile 2015,
2018, IRDA Statistical Handbook 2016-17, Edelweiss Research
Mutual Fund
investments are subject to market risks, read all scheme related documents
carefully.
About Aditya Birla Sun Life Mutual Fund, an Aditya
Birla Capital Company
Established
in 1994, Aditya Birla Sun Life Mutual Fund (ABSLMF), is co-sponsored by Aditya
Birla Capital Limited (ABCL) and Sun Life (India) AMC Investments Inc.
Having
total domestic assets under management (AUM) of over Rs. 2464 billion for the
quarter ended March 31st, 2019, ABSLMF is one of the leading Fund Houses in
India based on domestic average AUM as published by the Association of Mutual
Funds of India (AMFI). An impressive mix of reach, a wide range of product
offerings across equity, debt, balanced as well as structured asset classes and
sound investment performance has helped the company garner around 7 million
investor folios as of March 31st, 2019.
With
a pan India presence across 270 locations, ABSLMF is committed to deepening
mutual fund penetration in the country. The company is ceaselessly working to
enhance the appeal of mutual funds across a wider set of investors and advisors
across India. Part of this effort includes introducing smart solutions,
user-friendly services and conveniences which simplify mutual fund processes
with digitization for both – investors as well as distribution partners.
ABSLAMF provides sector specific equity schemes, fund of fund schemes, hybrid
and monthly income funds, debt and treasury products and offshore funds.
Company
Information: Aditya Birla Sun Life AMC Limited (formerly known as Birla Sun
Life Asset Management Company Limited, Investment Manager for Aditya Birla Sun
Life Mutual Fund) One India Bulls Centre, Tower 1, 17th Floor, Jupiter Mill
Compound, 841, S.B. Marg, Elphinstone Road, Mumbai - 400 013. Tel.: 4356 8000.
Website: www.adityabirlacapital.com. CIN:
U65991MH1994PLC080811
Aditya
Birla Capital Limited (ABCL), is the holding company of all the financial
services businesses of the Aditya Birla Group. With a strong presence across
the life insurance, asset management, private equity, corporate lending,
structured finance, project finance, general insurance broking, wealth
management, equity, currency and commodity broking, online personal finance
management, housing finance, pension fund management and health insurance
business, ABCL is committed to serving the end-to-end financial services needs
of its retail and corporate customers. Anchored by more than 18,000 employees,
ABCL has a nationwide reach and more than 2,00,000 agents / channel partners.
Aditya Birla Capital, through its
subsidiaries and joint ventures, manages aggregate assets worth Rs. 3,000
billion and has a lending book of Rs. 630 billion as of March 31st, 2019.
About Sun Life Financial
Sun Life is
a leading international financial services organization providing insurance,
wealth and asset management solutions to individual and corporate Clients. Sun
Life has operations in a number of markets worldwide, including Canada, the
United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan,
Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda.
As of March 31, 2019, Sun Life had total assets under management of $1,011
billion. For more information please visit www.sunlife.com
Sun Life
Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine
(PSE) stock exchanges under the ticker symbol SLF.
No comments:
Post a Comment